Alumni community member
Spermosens
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment.
![](https://usercontent.one/wp/www.smileventurehub.com/wp-content/uploads/2020/08/spermosens_john_lempert.jpg)
Did you know?
15% of the couples are globally affected by infertility, with male-factor accounting for 50% of the global infertility.